Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00351754 · ClinicalTrials.gov registry record · Phase 4
Detection of Pulmonary Embolism With CECT
A Phase 4 study of Pulmonary Embolism, sponsored by Bracco Diagnostics.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT00351754 is a Phase 4 study of Pulmonary Embolism that has completed, run by Bracco Diagnostics. The registered enrollment target is 120 participants, below the 3,056-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00351754, a Phase 4 study of Pulmonary Embolism, has completed, sponsored by Bracco Diagnostics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare the vascular enhancement of the two contrast agents in pulmonary Multi-detector CTA
Conditions Studied
Interventions
- DRUG Isovue
Study Locations (1)
New Jersey
- Bracco Diagnostics, Inc. - Princeton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2006-07 |
| Est. Completion | 2006-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00351754
The ClinicalTrials.gov registry entry for NCT00351754 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,056-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (96% lower). The listed sponsor is Bracco Diagnostics, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Isovue is the first listed.
NCT00351754 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT00351754 about?
NCT00351754 is a clinical study titled "Detection of Pulmonary Embolism With CECT". To compare the vascular enhancement of the two contrast agents in pulmonary Multi-detector CTA
What is the current status of trial NCT00351754?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2006-07. Estimated completion is 2006-11.
What conditions does trial NCT00351754 study?
This clinical trial studies the following conditions: Pulmonary Embolism.
What interventions are being tested in trial NCT00351754?
The interventions under investigation include: Isovue (DRUG).
Who is sponsoring clinical trial NCT00351754?
This trial is sponsored by Bracco Diagnostics, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00351754 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE
ACTIVE NOT RECRUITING · Phase 4
-
Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
ACTIVE NOT RECRUITING · Phase 4
-
Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital
ACTIVE NOT RECRUITING · Phase 4
-
Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
COMPLETED · Phase 4
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.